semaglutide vs tirzepatide weight loss efficacy Tirzepatide: Which GLP-1 Wins for Loss? Tirzepatide outperformed semaglutide weight-loss drug
Description
The GLP-1 Market size was valued at USD 52.82 billion in 2025 and is expected to grow at a CAGR of 10.9% from 2026 to 2034.
The metabolite-gene layer revealed enrichment in galactose metabolism, platelet homeostasis, and nitric-oxide pathways
New York, NY, June 23, 2026 (GLOBE NEWSWIRE) -- Zealthy, a telehealth platform that connects patients with licensed healthcare providers, announced today the expansion of its online program designed to help eligible adults with type 2 diabetes explore Ozempic treatment options through remote medical evaluations, insurance coordination, prescription management, and ongoing provider support
Ozempic face may be one of the most talked-about medications in recent years
